Hennion & Walsh Asset Management Inc. Acquires New Shares in HealthEquity, Inc. (NASDAQ:HQY)

Hennion & Walsh Asset Management Inc. bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,240 shares of the company’s stock, valued at approximately $215,000.

Several other institutional investors also recently bought and sold shares of HQY. Wasatch Advisors LP increased its holdings in shares of HealthEquity by 6.6% during the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after acquiring an additional 483,269 shares during the last quarter. State Street Corp boosted its position in HealthEquity by 0.8% during the third quarter. State Street Corp now owns 3,131,900 shares of the company’s stock worth $256,346,000 after purchasing an additional 23,613 shares during the period. Clearbridge Investments LLC grew its holdings in HealthEquity by 1.9% during the second quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock valued at $204,915,000 after purchasing an additional 43,491 shares during the last quarter. Mackenzie Financial Corp raised its position in shares of HealthEquity by 16.0% in the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after purchasing an additional 325,906 shares during the period. Finally, Geode Capital Management LLC raised its position in shares of HealthEquity by 0.7% in the third quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock valued at $170,197,000 after purchasing an additional 15,145 shares during the period. 99.55% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HQY has been the topic of a number of research analyst reports. The Goldman Sachs Group started coverage on shares of HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Bank of America raised their price target on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Royal Bank of Canada boosted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. JMP Securities raised their target price on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Finally, Mizuho initiated coverage on HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.

HealthEquity Stock Up 2.3 %

HQY opened at $104.74 on Wednesday. The company has a market capitalization of $9.08 billion, a P/E ratio of 96.09, a P/E/G ratio of 1.80 and a beta of 0.54. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The firm’s fifty day moving average price is $99.04 and its two-hundred day moving average price is $86.92. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $105.82.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter last year, the business earned $0.40 EPS. On average, analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Buying and Selling at HealthEquity

In related news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the completion of the sale, the director now owns 66,469 shares in the company, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 34,289 shares of company stock valued at $3,355,718. 2.20% of the stock is currently owned by corporate insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.